We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COUP
3026
DELISTED
Coupa Software Incorporated
COUP
$6K ﹤0.01%
+98
New +$5.21K
NH
3027
DELISTED
NantHealth, Inc
NH
$6K ﹤0.01%
+114
New +$5.64K
ZEAL
3028
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$6K ﹤0.01%
507
-784
-61% -$11.9K
GPL
3029
DELISTED
Great Panther Mining Limited
GPL
$6K ﹤0.01%
553
-268
-33% -$3.27K
GFED
3030
DELISTED
Guaranty Federal Bancshares In
GFED
$6K ﹤0.01%
+252
New +$5.94K
VRS
3031
DELISTED
Verso Corporation
VRS
$6K ﹤0.01%
294
-35,712
-99% -$681K
EGOV
3032
DELISTED
NIC Inc
EGOV
$6K ﹤0.01%
383
-2,105
-85% -$32K
HUSN
3033
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
$6K ﹤0.01%
+165
New +$8.7K
BGG
3034
DELISTED
Briggs & Stratton Corp.
BGG
$6K ﹤0.01%
+355
New +$6.75K
NVLN
3035
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$6K ﹤0.01%
1,661
+427
+35% +$1.72K
WAGE
3036
DELISTED
WageWorks, Inc.
WAGE
$6K ﹤0.01%
116
-9,081
-99% -$414K
PES
3037
DELISTED
Pioneer Energy Services Corp.
PES
$6K ﹤0.01%
1,097
-6,996
-86% -$31.1K
ANCX
3038
DELISTED
Access National Corp
ANCX
$6K ﹤0.01%
+203
New +$5.82K
LKM
3039
DELISTED
Link Motion Inc.
LKM
$6K ﹤0.01%
+5,255
New +$7.59K
SODA
3040
DELISTED
SodaStream International Ltd
SODA
$6K ﹤0.01%
75
-5,932
-99% -$536K
EGC
3041
DELISTED
Energy XXI Gulf Coast, Inc. Common Stock
EGC
$6K ﹤0.01%
+695
New +$4.74K
EVHC
3042
DELISTED
Envision Healthcare Holdings Inc
EVHC
$6K ﹤0.01%
+140
New +$5.75K
MTGE
3043
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$6K ﹤0.01%
331
-4,517
-93% -$86.4K
CYS
3044
DELISTED
CYS Investments Inc.
CYS
$6K ﹤0.01%
780
-6,142
-89% -$43.9K
ABUS icon
3045
Arbutus Biopharma
ABUS
$915M
$5K ﹤0.01%
712
-1,836
-72% -$10.9K
AFMD
3046
DELISTED
Affimed
AFMD
$5K ﹤0.01%
289
+230
+390% +$4.85K
AIFA
3047
All In FutureTech Alliance Inc
AIFA
$12.8M
$5K ﹤0.01%
87
ARCC icon
3048
Ares Capital
ARCC
$14.4B
$5K ﹤0.01%
314
-760
-71% -$12.5K
ARDX icon
3049
Ardelyx
ARDX
$997M
$5K ﹤0.01%
1,460
-2,887
-66% -$13.4K
BCLI
3050
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$5K ﹤0.01%
92
+11
+14% +$647

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.